AT2R −1332 G:A polymorphism and its interaction with AT1R 1166 A:C, ACE I/D and MMP-9 −1562 C:T polymorphisms: Risk factors for susceptibility to preeclampsia-Reference-Cited by-同舟云学术

AT2R −1332 G:A polymorphism and its interaction with AT1R 1166 A:C, ACE I/D and MMP-9 −1562 C:T polymorphisms: Risk factors for susceptibility to preeclampsia

Published:2014-03 Issue:1 Volume:538 Page:176-181
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Rahimi Zohreh,Rahimi Ziba,Aghaei Amir,Vaisi-Raygani Asad

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference31 articles.

1. Renin–angiotensin system genes polymorphism in Egyptians with premature coronary artery disease;Abd El-Aziz;Gene,2012

2. Preeclampsia in North Indian women: the contribution of genetic polymorphisms;Agarwal;J. Obstet. Gynaecol. Res.,2011

3. Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations;Akbar;Acta Obstet. Gynecol. Scand.,2009

4. The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (−1332G/A) in a cohort of 509 families with premature coronary artery disease;Alfakih;Eur. Heart J.,2005

5. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation;Anne;Cardiovasc. Res.,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1–7)/MasR signaling in normal and hypertensive pregnancy;Biochemical Pharmacology;2024-02

2. Research Progress of AGT and MTHFR Genes in the Occurrence of Preeclampsia in Qinghai Province;Medical Diagnosis;2023

3. The effect of AT1R-1166A/C and AT2R-1675A/G polymorphisms on susceptibility to preeclampsia: A systematic review and meta-analysis;Medicine;2022-11-11

4. The genetic risk factors for pregnancy‐induced hypertension: Evidence from genetic polymorphisms;The FASEB Journal;2022-06-13

5. Epidemiological Evidence Between Variants in Matrix Metalloproteinases-2, -7, and -9 and Cancer Risk;Frontiers in Oncology;2022-04-28